Methods to Evaluate and Correct for Bias in Patient-Reported Outcomes in Clinical Trials: Advancing the Validity of Patient-Centric Drug Development — Invited Papers
Biopharmaceutical Section, Health Policy Statistics Section, Biometrics Section
Organizer(s): Joseph C. Cappelleri, Pfizer Inc.; Jessica Roydhouse, Menzies Institute for Medical Research, University of Tasmania